Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. - sprookjes - yvandenbroek - TriplyDB

Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.

Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.

http://www.wikidata.org/entity/Q36375147

about

Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1 Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines Lung self-assembly is modulated by tissue surface tensions Endothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy.Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.Control of stromal keratitis by inhibition of neovascularization Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.Cigarette smoke-induced CXCR3 receptor up-regulation mediates endothelial apoptosis.Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.MicroRNAs in the human pituitary.Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity.The activity of aminoacyl-tRNA synthetase-interacting multi-functional protein 1 (AIMP1) on endothelial cells is mediated by the assembly of a cytoskeletal protein complex.A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro.Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo.Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells.Regulation of EMAP II by hypoxia.Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.Pro-EMAP II is not primarily cleaved by caspase-3 and -7.Epithelial-mesenchymal interactions are linked to neovascularization.Characterization of p43(ARF), a derivative of the p43 component of multiaminoacyl-tRNA synthetase complex released during apoptosis.Aminoacyl tRNA synthetase complex interacting multifunctional protein 1 simultaneously binds Glutamyl-Prolyl-tRNA Synthetase and Scaffold Protein Aminoacyl tRNA synthetase complex interacting multifunctional protein 3 of the Multi-tRNA Synthetase Co The cytokine portion of p43 occupies a central position within the eukaryotic multisynthetase complex.Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis.

P2860

Q24292006-21752968-3AF3-4774-A186-B27ACA33898C Q24292091-CE865DDC-1901-47A2-B962-BAF9C6B3B3B2 Q24800958-B6E9B646-3D1A-4C3D-99D4-9DAE8787EB63 Q28138764-CAD1B2BD-5060-417B-AF4B-681FE3A6A781 Q28246743-CDD67213-A3AA-4575-8533-176272A2F055 Q28298488-A772F8DF-DEDD-44D5-A7B9-933B6F8D5162 Q30500267-9B2B063F-3D24-4C9C-9DE8-88F8974038D8 Q33847497-3962B353-0780-4FAD-AFB8-E4ABAF60B541 Q34193685-1596B371-96D0-4F65-93B4-E3CF6E29744E Q34226670-61BEBD2F-BB2B-49D5-8FEA-49367CA5F13C Q34313870-9EADDD8E-133F-44DB-9EC4-CFA8D0F6236F Q34789755-2B3091A1-14AC-4BCB-839B-34C1A72D5CED Q34995850-DB2A7717-C30A-4D01-9420-34E8EA193B28 Q35015668-F034CB98-A332-449B-B2DC-72D70D9D2D05 Q35351996-0C7F1E54-31DC-4237-8F19-DABE352403B1 Q35746765-0C142B85-1940-42DE-8F13-F39575768B69 Q35829757-3D5EEC55-D339-4990-846A-1910DBD422F1 Q36539593-2B5C0EE6-4C62-45E4-937B-03340CDEB822 Q36744817-71AF9F3A-AA46-421A-8E27-F0C8523BCFE4 Q37038009-998805F7-5E0A-477E-BDC7-34AF4240A4A7 Q37885843-9C570C58-7DB8-4E72-9916-13D7F1A14965 Q38288255-170F4CBF-289D-42B6-8394-7503D7733C92 Q38442317-283E61AA-4C80-40F6-B80B-63C2395BA51D Q39574270-EF3282E8-C631-4459-81FD-A0157A35A427 Q39812178-A4966E75-2F07-4D78-AF60-2B8CD1E85414 Q41631319-E3E45C23-3700-4800-B3AC-FBBC2774F7EF Q41744886-62C48CFE-D4FB-4B2C-9530-3CAA37F4EA5E Q41860362-2D6FFE24-4517-46B6-A437-BE31C7489883 Q42004172-6361B668-3A1E-40A8-9E80-83CED145865A Q42148044-C9B7D00C-20C4-4DE3-ACA7-D1F49054AF2E Q43988484-0CC707CA-E22C-42D8-927F-56DEE6A7A039 Q44362680-74F4B3D0-29C7-45AF-89AC-BBFCA2A33163 Q51064831-4E7DC8FD-8DAA-4025-84C0-4F33F8EFF855 Q52313647-212DC002-AAA6-4F55-B270-3BFF656A62BC Q52539024-94144AC0-2B48-40D9-A484-794CBE0A95BB Q53665237-122BD863-2A12-450E-9292-353E7A5C48BD

P2860

Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.

http://www.wikidata.org/entity/Q36375147

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Endothelial-monocyte activatin ...... in growing endothelial cells.

@ast

Endothelial-monocyte activatin ...... in growing endothelial cells.

@en

type

label

Endothelial-monocyte activatin ...... in growing endothelial cells.

@ast

Endothelial-monocyte activatin ...... in growing endothelial cells.

@en

prefLabel

Endothelial-monocyte activatin ...... in growing endothelial cells.

@ast

Endothelial-monocyte activatin ...... in growing endothelial cells.

@en

P1433

Q36375147-03022074-4925-4C99-BF83-E4E37BBBE1CB

P1476

Q36375147-21783E0A-358A-41B3-8DE9-BFF76B1FD237

P2093

Q36375147-0CD7B4FD-E12E-4D96-B038-D46C069B2BD4

Q36375147-27FEEB31-5C19-41BC-B849-3385C497CD34

Q36375147-3F4397F0-86FE-4364-B93E-456366A2665D

Q36375147-676DA928-206C-4CA1-B245-A52E2031B5FB

Q36375147-75525CEB-B5EA-4C31-B4BC-D0A8A6821972

Q36375147-7CE5C54E-2F3D-49F9-A435-57F9EBE17A68

Q36375147-A293297B-1876-4425-B670-63385666BB1F

Q36375147-BE51483F-D74E-4B70-96A6-D7A784BDD6D1

Q36375147-E1B51546-88C4-4F2A-BBE6-5CD0D1802FD2

Q36375147-E7D711FC-F902-4959-826B-96D2DFA8A9F3

P2860

Q36375147-09D89D92-F49D-4E4B-8E29-3AAB2ECF6490

Q36375147-0EDE9594-8955-48D6-804F-CE14E74B312F

Q36375147-112E0A98-3225-4C06-BA22-A10F8E15705F

Q36375147-158D1FA2-CF5F-45BF-84CD-3B5433780955

Q36375147-1724AFD3-D61A-4AFB-BCF9-C9A8594ACD23

Q36375147-188BE0C7-3557-406E-957F-E953ADE7CCA1

Q36375147-1CF1762A-DECB-442C-87D4-97CEFAB8142C

Q36375147-28EC6DBF-A87F-42C0-AAD6-89C1A0A68289

Q36375147-2C538F01-354C-4D57-AF69-FE76CD091D83

Q36375147-3C4F6303-AEDC-4D29-BAAA-159A4FA844C2

P304

Q36375147-291D0520-4216-4EF4-B8A3-13A58593BA5D

P31

Q36375147-0F61F59A-BDB2-47BA-8FAC-3A5F9F0F273F

P356

Q36375147-3478183A-A9C3-42F6-87E1-C46D4E627500

P407

Q36375147-83DA3012-0BEF-4647-A13F-48A8C4E00000

P433

Q36375147-9BA5FEC6-E461-46F9-BEBA-3258E9345FC9

P478

Q36375147-EB5B7049-2952-48EA-9259-2717203B8A94

P577

Q36375147-735DFB9A-7266-4F14-9E41-67112AFC77C0

P5875

Q36375147-C58431FA-EE5F-486E-9CB1-30AB80CA2D2F

P698

Q36375147-DE6EC163-FCAC-4CC7-A460-360765BE4648

P921

Q36375147-B87F04E7-2E60-45D7-AF90-BE3EEAC37429

Q36375147-C38C2192-9A62-41F9-A654-BB1EAE8290A4

P932

Q36375147-7D9DBA8E-3B6B-4366-9596-D329E8FEEAE1

P356

P1433

Journal of Experimental Medicine

P1476

Endothelial-monocyte activatin ...... in growing endothelial cells.

@en

P2093

D Stern

http://www.w3.org/2001/XMLSchema#string

J Brett

http://www.w3.org/2001/XMLSchema#string

J Chabot

http://www.w3.org/2001/XMLSchema#string

J Hayward

http://www.w3.org/2001/XMLSchema#string

J Kandel

http://www.w3.org/2001/XMLSchema#string

J L Wautier

http://www.w3.org/2001/XMLSchema#string

J Li

http://www.w3.org/2001/XMLSchema#string

M A Schwarz

http://www.w3.org/2001/XMLSchema#string

O Chappey

http://www.w3.org/2001/XMLSchema#string

P Lo Gerfo

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms

Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II

Basement membrane complexes with biological activity

Angiogenesis in cancer, vascular, rheumatoid and other disease

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

What is the evidence that tumors are angiogenesis dependent?

P304

341-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.190.3.341

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236242280

http://www.w3.org/2001/XMLSchema#string

P698

10430623

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2195582

http://www.w3.org/2001/XMLSchema#string